Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
In Re: Marco Guldenaar Holding B.V., Appeal No. 2017-2465 (Fed. Cir. Dec. 28, 2018)
The Federal Circuit affirmed the final written decision of the Patent Trial and Appeal Board (“PTAB”) finding claims directed to a dice game ineligible for patenting under 35 U.S.C. § 101. The case is more remarkable for the concurring decision, discussed below, than the holding.
The patent application related to “dice games intended to be played in gambling casinos, in which a participant attempts to achieve a particular winning combination of subsets of the dice.” The novelty of the claimed invention asserted was the markings on the dice, which had only particular faces marked. The Board affirmed the patent examiner’s rejection of certain claims as being directed to patent-ineligible subject matter under § 101 as well as obvious under the printed matter doctrine.
The Court recited the two-step framework to determine whether claimed subject matter is patent-eligible set in Alice Corp. v. CLS Bank Int’l, 573 U.S. 208 (2014). The Court held that Marco’s claimed “method of playing a dice game” was directed to a method of conducting a wagering game, with the probabilities based on dice rather than on cards and, therefore, directed to an abstract idea.
Written by: Scott D. Eads and Nika Aldrich, Schwabe Williamson & Wyatt
Contributor: Cristin Wagner
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…